Parkinson's Disease Therapeutics Market Report

Global and Region Parkinson's Disease Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：139
  • REPORT CODE：GMM1020812
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Parkinson's Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Parkinson's Disease Therapeuticsmarket, defines the market attractiveness level of Parkinson's Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Parkinson's Disease Therapeutics industry, describes the types of Parkinson's Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parkinson's Disease Therapeutics market and the development prospects and opportunities of Parkinson's Disease Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parkinson's Disease Therapeutics market in Chapter 13.

    By Player:

    • Astellas Pharma

    • Merck

    • Apokyn

    • Akorn

    • HLundbeck

    • FHoffmann-La Roche

    • Stada Arzneimittel

    • Boehringer Ingelheim

    • Teva Pharmaceutical

    • Desitin Arzneimittel

    • GSK

    • Endo Pharmaceuticals

    • US WorldMeds

    • Valeant

    • Novartis

    • Valeant Pharmaceuticals

    • Abbvie

    • Orion

    • Valeant Pharmaceuticals

    By Type:

    • Medications Therapeutics

    • Medical Devices Therapeutics

    By End-User:

    • Under 40 Years Old

    • 40-65 Years Old

    • Above 65 Years Old

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Parkinson's Disease Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Parkinson's Disease Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Parkinson's Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Parkinson's Disease Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Parkinson's Disease Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.2 United States Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.3 Europe Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.4 China Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.5 Japan Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.6 India Parkinson's Disease Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Parkinson's Disease Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Parkinson's Disease Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Parkinson's Disease Therapeutics Consumption Forecast (2022-2028)

    9 Global Parkinson's Disease Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Parkinson's Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Medications Therapeutics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Medical Devices Therapeutics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Parkinson's Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Under 40 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global 40-65 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Above 65 Years Old Consumption and Growth Rate (2017-2022)

    10 Global Parkinson's Disease Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Medications Therapeutics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Medical Devices Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    11 Global Parkinson's Disease Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Parkinson's Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Parkinson's Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Parkinson's Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Parkinson's Disease Therapeutics Market Competitive Analysis

    • 14.1 Astellas Pharma

      • 14.1.1 Astellas Pharma Company Details

      • 14.1.2 Astellas Pharma Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Pharma Parkinson's Disease Therapeutics Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Parkinson's Disease Therapeutics Product and Service

    • 14.3 Apokyn

      • 14.3.1 Apokyn Company Details

      • 14.3.2 Apokyn Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Apokyn Parkinson's Disease Therapeutics Product and Service

    • 14.4 Akorn

      • 14.4.1 Akorn Company Details

      • 14.4.2 Akorn Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Akorn Parkinson's Disease Therapeutics Product and Service

    • 14.5 HLundbeck

      • 14.5.1 HLundbeck Company Details

      • 14.5.2 HLundbeck Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 HLundbeck Parkinson's Disease Therapeutics Product and Service

    • 14.6 FHoffmann-La Roche

      • 14.6.1 FHoffmann-La Roche Company Details

      • 14.6.2 FHoffmann-La Roche Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 FHoffmann-La Roche Parkinson's Disease Therapeutics Product and Service

    • 14.7 Stada Arzneimittel

      • 14.7.1 Stada Arzneimittel Company Details

      • 14.7.2 Stada Arzneimittel Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product and Service

    • 14.8 Boehringer Ingelheim

      • 14.8.1 Boehringer Ingelheim Company Details

      • 14.8.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product and Service

    • 14.9 Teva Pharmaceutical

      • 14.9.1 Teva Pharmaceutical Company Details

      • 14.9.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product and Service

    • 14.10 Desitin Arzneimittel

      • 14.10.1 Desitin Arzneimittel Company Details

      • 14.10.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product and Service

    • 14.11 GSK

      • 14.11.1 GSK Company Details

      • 14.11.2 GSK Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GSK Parkinson's Disease Therapeutics Product and Service

    • 14.12 Endo Pharmaceuticals

      • 14.12.1 Endo Pharmaceuticals Company Details

      • 14.12.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product and Service

    • 14.13 US WorldMeds

      • 14.13.1 US WorldMeds Company Details

      • 14.13.2 US WorldMeds Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 US WorldMeds Parkinson's Disease Therapeutics Product and Service

    • 14.14 Valeant

      • 14.14.1 Valeant Company Details

      • 14.14.2 Valeant Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Valeant Parkinson's Disease Therapeutics Product and Service

    • 14.15 Novartis

      • 14.15.1 Novartis Company Details

      • 14.15.2 Novartis Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis Parkinson's Disease Therapeutics Product and Service

    • 14.16 Valeant Pharmaceuticals

      • 14.16.1 Valeant Pharmaceuticals Company Details

      • 14.16.2 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Product and Service

    • 14.17 Abbvie

      • 14.17.1 Abbvie Company Details

      • 14.17.2 Abbvie Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Abbvie Parkinson's Disease Therapeutics Product and Service

    • 14.18 Orion

      • 14.18.1 Orion Company Details

      • 14.18.2 Orion Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Orion Parkinson's Disease Therapeutics Product and Service

    • 14.19 Valeant Pharmaceuticals

      • 14.19.1 Valeant Pharmaceuticals Company Details

      • 14.19.2 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Valeant Pharmaceuticals Parkinson's Disease Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Parkinson's Disease Therapeutics

    • Figure Parkinson's Disease Therapeutics Picture

    • Table Global Parkinson's Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Parkinson's Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Parkinson's Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Parkinson's Disease Therapeutics Consumption by Country (2017-2022)

    • Figure United States Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Parkinson's Disease Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Parkinson's Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medications Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Devices Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Under 40 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global 40-65 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Above 65 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Medications Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Devices Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Under 40 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 40-65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Parkinson's Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Parkinson's Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Parkinson's Disease Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Parkinson's Disease Therapeutics Product and Service

    • Table Apokyn (Foundation Year, Company Profile and etc.)

    • Table Apokyn Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apokyn Parkinson's Disease Therapeutics Product and Service

    • Table Akorn (Foundation Year, Company Profile and etc.)

    • Table Akorn Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akorn Parkinson's Disease Therapeutics Product and Service

    • Table HLundbeck (Foundation Year, Company Profile and etc.)

    • Table HLundbeck Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table HLundbeck Parkinson's Disease Therapeutics Product and Service

    • Table FHoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table FHoffmann-La Roche Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann-La Roche Parkinson's Disease Therapeutics Product and Service

    • Table Stada Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel Parkinson's Disease Therapeutics Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Parkinson's Disease Therapeutics Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Parkinson's Disease Therapeutics Product and Service

    • Table Desitin Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Desitin Arzneimittel Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Desitin Arzneimittel Parkinson's Disease Therapeutics Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Parkinson's Disease Therapeutics Product and Service

    • Table Endo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo Pharmaceuticals Parkinson's Disease Therapeutics Product and Service

    • Table US WorldMeds (Foundation Year, Company Profile and etc.)

    • Table US WorldMeds Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table US WorldMeds Parkinson's Disease Therapeutics Product and Service

    • Table Valeant (Foundation Year, Company Profile and etc.)

    • Table Valeant Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Parkinson's Disease Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Parkinson's Disease Therapeutics Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Parkinson's Disease Therapeutics Product and Service

    • Table Orion (Foundation Year, Company Profile and etc.)

    • Table Orion Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orion Parkinson's Disease Therapeutics Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Parkinson's Disease Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US